Jianmin Liu, MD

Research interests: clinical, basic and translational researches for cerebrovascular disease

Jianmin Liu, MD, is Chief Physician, Professor, PhD Supervisor, Director of the Cerebrovascular Center of Changhai Hospital. Dr. Liu has long been engaged in medical treatment, teaching and scientific research of neurological diseases including cerebrovascular disease, brain tumour, epilepsy and traumatic brain injury. He specialises in the treatment of cerebrovascular diseases and has extensive experience in intracranial complex aneurysms, stenosis of cerebral arteries, cerebral infarction, cerebral (spinal) arteriovenous malformation and arteriovenous fistulae. He is one of the pioneers in the field of neurointerventional therapy in China and has created a series of innovative treatment techniques.

Dr. Liu is currently the Deputy Director of the Expert Committee of the Million Disability Reduction Project of the National Health Commission, the Deputy Director of the Expert Committee of the National Stroke Center Management, the Vice-Chairman of the Interventionalist Branch of the Chinese Medical Association, the Chairman of the Cerebrovascular Disease Intervention and Rehabilitation Committee of the Chinese Society of Rehabilitation Medicine, and the Standing Member of the Neurosurgery Branch of the Chinese Medical Association. He founded the Oriental Conference of Internation Neurovascology (OCIN) in 2001 which was successfully held annually, and founded the East Asian Conference on Neurointervention (EACoN) in 2008 and served as the rotating president (2008, 2011, 2014, 2017 and 2021). He organized joint conferences with ALICE, LINNC, SNIS, ESMINT and served as a member of executive committee of WLNC .

Dr. Liu has led several large clinical trials including DIRECT-MT, ENCHANTED-2/MT, and MAGIC-MT etc. which were published in NEJM, Lancet and other medical journals. He established OCEAN-Consortium and OCIN Core Lab, and is currently carrying out 12 MT series trials. He led the development of Tonbridge, Fastunnel, COMETIU and other medical devices, and founded the Oriental Cerebrovascular Innovation Club (OCI) and the Oriental Pan-vascular Devices Innovation College (OPIC) in University of Shanghai for Science and Technology to continually carry out innovative research and development of medical devices.

Dr. Liu has published a total of 553 papers (including 1 in NEJM and 2 in The Lancet). He has edited 8 monographs and formulated 10 guidelines or consensuses. He has been authorised with 92 national patents (12 invention patents). He is actively involved in residency and fellowship education and currently serves as a PhD advisor at both Naval Medical University and Shanghai University of Technology. He is also a Fellow of the Royal College of Surgeons of England.

Adnan Siddiqui

Research interests: complementary microsurgical, radiosurgical and endovascular techniques for the comprehensive management of cerebrovascular conditions

Dr. Adnan H. Siddiqui, is Distinguished Professor and Vice Chairman in the Department of Neurosurgery (UBNS) at the State University of New York at Buffalo’s Jacobs School of Medicine and Biomedical Sciences. He joined UBNS in December 2006. Dr. Siddiqui completed fellowship training in Interventional Neuroradiology, Cerebrovascular Surgery and Neurocritical Care from Thomas Jefferson University in Philadelphia. He completed his Neurosurgical residency at Upstate Medical University and received his PhD in Neuroscience from the University of Rochester and medical degree from Aga Khan University in Pakistan. He is a Fellow of the American Association of Neurological Surgeons, American College of Surgeons and American Heart Association. He is profoundly indebted to his mentors Nick Hopkins, Robert Rosenwasser, Charles Hodge and Shirley Joseph in shaping his career as a dual-trained cerebrovascular surgeon, clinician scientist and entrepreneur.

Dr. Siddiqui has special interest and expertise in the performance of complementary microsurgical, radiosurgical and endovascular techniques for the comprehensive management of cerebrovascular conditions. This spectrum of disease includes aneurysms and arteriovenous malformations, as well as dural, cavernous and spinal fistulae. He has special interests in endovascular management of acute ischemic stroke, as well as endovascular and microsurgical management of extracranial and intracranial vascular occlusive disease. Other clinical interests include endovascular management of intractable epistaxis, facial vascular malformations, head, neck, and brain tumor embolization and microsurgical resection of skull base tumors.

Dr. Siddiqui has over 600 peer reviewed publications, more than 50 chapters, almost 50,000 citations and an H index of 89. He is particularly proud of representing Buffalo and the US at most major cerebrovascular conferences around the world with over 400 presentations to date. He has designed, conducted and lead multiple major national and international clinical trials and currently serves as National and International PI for multiple major funded multi-site trials. These efforts have significantly contributed to the success of the department, which was ranked 7th in academic impact in North America by the Journal of Neurosurgery.

He serves as the Chief Executive Officer and Chief Medical Officer at the Jacobs Institute (JI) which is focused on entrepreneurship, development and education opportunities with partners in the medical technology industry including strategics, startups and individual inventors to advance the care of patients with vascular diseases. His goal is to improve the current offerings and translate technologies being developed at the Institute’s idea to reality (i2R) into therapeutic and commercial successes.

He leads the Canon Stroke and Vascular Research Center (CSVRC) at University at Buffalo. This multi-disciplinary center with multiple concurrent major NIH grants, houses neurosurgeons, neuroscientists, physicists and biomedical engineers working collaboratively on cutting edge research focused on neurovascular biology and pathology including stroke and aneurysms, imaging, simulation and hemodynamics. In addition, he serves as the Director of the Neurosurgical Stroke Service at the Gates Vascular Institute in Buffalo, one of the busiest Comprehensive Stroke Services in New York State and the United States.

Dr. Siddiqui has continuously served on multiple scientific and educational committees of American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS) and Society of NeuroInterventional Surgery (SNIS). He most recently served as Chairman of the Joint Section of Cerebrovascular Surgery of the AANS and CNS and Secretary for the SNIS (2020-2021). He currently serves on the CNS Executive Council. It has been a major focus for him to achieve consensus between the various organizations involved in fellowship training and credentialing for Neuroendovascular Surgery. He was a founding member of the Neuroendovascular Surgery Advisory Committee (NESAC) for Society of Neurological Surgery’s Committee for Advanced Sub-Specialty Training (CAST) and currently is a member of the American Board of Neurological Surgery’s (ABNS) Central Nervous System Endovascular Surgery Advisory Committee (CESAC). This has been an extremely important role, which is profoundly affecting the training and education pathways of neuroendovascular specialists.

He serves as a Neurosurgeon Director on the Executive Committee of the SNIS Patient Safety Organization which runs the NVQI-QOD Quality Outcomes Registry. He has also assumed the role of Co-Chair of the Neurological Devices Working group for the Medical Device Industry Consortium (MDIC), a not-for-profit group consisting of FDA, CMS and Industry partners dedicated to resuming Early Feasibility Studies (EFS) also known as First in man studies in the United States.

In recognition of his achievements, Dr. Siddiqui has been honored with the 2021-2022 SUNY Chancellor’s Award for Excellence in Scholarship and Creative Activities, the invitation to present the M. Gazi Yasargil Lecture at the AANS Annual Meeting in 2023, and has recently received a Distinguished Professorship from the University at Buffalo.

All these efforts as a microsurgeon, endovascular surgeon, scientist and trialist, have allowed Dr. Siddiqui to gain unique insights into a critical and rapidly evolving specialty.

At the same time, these endeavors have required significant collaborations resulting in strong and trusting relationships with fellow neurosurgeons, neurologists, neuroradiologists, scientists, engineers, regulatory officers and industry.

Jens Fiehler

Research interests: imaging analysis and advanced study methodology in Interventional Neuroradiology

Professor Jens Fiehler is the Director of the Department of Diagnostic and Interventional Neuroradiology in the University Medical Center Hamburg-Eppendorf in Germany. He has published more than 700 peer-reviewed papers and he aims to support and foster high-quality research in Interventional Neuroradiology. His main research focus is imaging analysis and advanced study methodology in Interventional Neuroradiology. He is currently managing the imaging core lab of more than thirty studies. Jens Fiehler was a founding member of ESMINT and served in the Executive Committee, and its president. He is now a Board member and responsible for ESMINT’s “Stroke Outreach” program.